ABSTRACT-Effects of a new antiulcer drug, MCI-727, on gastric and duodenal lesions, gastric secretion and gastric motility were studied in comparison with cimetidine and teprenone. MCI-727 dose-dependently (3-100 mg/kg, p.o. or i.d.) inhibited the development of acute gastric or duodenal lesions such as pyrolus ligation-, waterimmersion stress-, indomethacin-, HCl-, HCl-ethanol-induced gastric lesions and cysteamine-induced duodenal lesions in rats and histamine-induced duodenal lesions in guinea pigs. These antiulcer effects exceeded those of cimetidine or teprenone. Repeated administration of MCI-727 (0.3-3 mg/kg/day, p.o., for 10 days) significantly promoted the spontaneous healing of acetic acid-induced chronic gastric ulcers. Concerning gastric acid secretion, MCI-727 selectively inhibited tetragastrin-stimulated acid secretion without effecting basal acid secretion and acid secretion by other stimuli. Cimetidine and teprenone inhibited acid secretion in several cases. MCI-727 and teprenone had inhibitory effects on gastric motility, although cimetidine had no effect. These results suggest that MCI-727 has a wide spectrum of antiulcer activity, and its mode of antiulcer action is different from that of cimetidine or teprenone.After the development of the histamine H2-receptor blocker cimetidine, antiulcer therapeutics has progressed rapidly. However, refinements are still required, because some problems, such as recurrence of ulcer, remain to be solved. In our laboratory, we have attempted to develop new antiulcer agents by synthesizing a number of aryl ethanoneoxim derivatives and evaluating their efficacy on some experimental ulcer models. Among the active compounds, MCI-727 ((Z)-2-(4-methylpiperazin-1-yl)-1-4-(2-phenyl-ethyl) phenylethanone oxime hydrochloride monohydrate) (Fig. 1) was selected for further pharmacological evaluation as the most promising one with low toxicity. In the present study, we determined the effects of MCI-727 on experimental gastric or duodenal ulcer models. We also examined its effects on gastric secretion